Results from the VISIBILITY Iliac Study: Primary and Cohort Outcomes at 9 Months

Keyphrases

• Stent 100%
• Major Adverse Events 100%
• Iliac 100%
• External Iliac Artery 100%
• Primary Patency 66%
• Target Vessel Revascularization 66%
• Arterial Lesions 66%
• Ankle-brachial Index 66%
• Adverse Event Rates 66%
• Visus 66%
• In(III) 33%
• United States 33%
• Myocardial Infarction 33%
• Atherosclerotic Lesions 33%
• Peri-procedural 33%
• Patient Cohort 33%
• In-hospital Death 33%
• Patient Characteristics 33%
• Ischemia 33%
• Target Lesion Revascularization 33%
• Stenotic Lesion 33%
• United Europe 33%
• Amputation 33%
• Balloon-expandable 33%
• Device Success 33%
• Primary Stenting 33%
• Specific Patient 33%
• Severity Grading 33%
• Severe Calcification 33%
• Iliac Vein Stenting 33%
• Iliac Stent 33%
• Peripheral Stent 33%
• Walking Impairment Questionnaire 33%
• Lesion Grades 33%

Medicine and Dentistry

• Iliac Artery 100%
• Adverse Event 75%
• Stenting 50%
• Target Vessel Revascularization 50%
• Artery Lesion 50%
• Ankle Brachial Index 50%
• Myocardial Infarction 25%
• Limb 25%
• Ischemia 25%
• Target Lesion Revascularization 25%
• Patient Characteristics 25%
• Amputation 25%
• Primary Outcome 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Artery Lesion 66%
• Heart Infarction 33%
• Ischemia 33%